Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pain, Postoperative 19Breast Neoplasms 16Pain 9Agnosia 8Lung Neoplasms 6Prostatic Neoplasms 5Neoplasms 5Stomach Neoplasms 4Postoperative Complications 3Colorectal Neoplasms 3Colonic Neoplasms 3Supratentorial Neoplasms 2Meningioma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Sleep Deprivation 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pain, Intractable 1Ovarian Neoplasms 1Ovarian Cysts 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Malignant Neoplasms of Male Genital Organs 1Liver Neoplasms 1Liver Diseases 1

Interventions

resiniferatoxin 3Ketamine 3Morphine 2Methadone 2Dexmedetomidine 2ziconotide 1substance P-saporin 1Standard of Care 1Sodium Chloride 1Ropivacaine 1Registries 1Pregabalin 1Passive Cutaneous Anaphylaxis 1Midazolam 1Lidocaine 1Infusion Pumps, Implantable 1Hydromorphone 1Fentanyl 1Calcium Dobesilate 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain, Intractable × Ropivacaine × Clear all
NCT04085120 2019-09-11

Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain

All India Institute of Medical Sciences

Phase NA Unknown
60 enrolled
Head & Neck

Cancer Pain, Oropharyngeal Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡